Fedegari is a world leader in sterilization and bio-decontamination technologies and a strategic partner to the pharmaceutical and biotech industries. Driven by innovation, Fedegari pioneers human-less aseptic manufacturing solutions designed around a fundamental principle: sterility assurance must be embedded from the earliest stages of process design. Building on over 70 years of expertise and guided by science, data-driven insights, and deep process knowledge, Fedegari delivers advanced solutions that help customers bring the most advanced sterile therapies to market, ensuring the highest standards of quality, safety, and accessibility for patients worldwide.
Sterility cannot be added at the end of manufacturing; it must be engineered from the very beginning. Every sterile manufacturing process starts by understanding the challenge behind it.
That is why we work closely with our customers before proposing a solution. By understanding their manufacturing system, contamination risks, regulatory requirements, and production objectives, we optimize the entire process, not just individual technologies, and develop an integrated sterile system tailored to each application, enhancing robustness, operational efficiency, and regulatory confidence.
Our multidisciplinary expertise merges process science, data-driven approaches, engineering, automation, and regulatory knowledge to deliver robust, scalable, and compliant manufacturing environments that support every stage of pharmaceutical production.
From washing, bio-decontamination, sterilization, aseptic processing, robotics, digital process control, and integrated automation, we bring these capabilities together into one coordinated manufacturing ecosystem.
Every manufacturing environment is different, which is why every customer journey begins with listening rather than prescribing.
From design, validation, CQV, training, digital compliance, upgrades, and lifecycle optimization, our teams work alongside customers throughout the entire manufacturing lifecycle.
Across our four Technology Centers worldwide (Italy, USA, Belgium, and Singapore) customers work side by side directly with Fedegari experts to develop, test, and validate solutions before implementation, while strengthening internal expertise through hands-on experience and shared knowledge.
By combining practical know-how, data-driven insights, and long-term collaboration, we help drive better decisions, improved performance, and greater regulatory confidence.
Cell & Gene Therapies are reshaping personalized medicine. But how can these life-saving treatments become scalable, reliable, and accessible to patients worldwide?
In this video, we explore how expertise in aseptic manufacturing, pharmaceutical scalability, advanced robotics, and AI-driven automation can converge to transform the future of advanced therapies.
By integrating technology, process expertise, and industrial governance into a single ecosystem, we are helping create manufacturing models that make personalized therapies more scalable, reliable, and accessible to patients.
Because innovation creates value only when it improves lives.
Science drives our decisions. Courage drives our innovation.
Being Clever means transforming scientific knowledge, process expertise, and manufacturing data into smarter approaches to complex challenges.
Being Braver means applying that understanding to industrialize the therapies of tomorrow through sterilization, aseptic processing, robotics, automation, and digital technologies.
By integrating science, engineering, and innovation, we help customers develop advanced sterile manufacturing solutions that make therapies safer, more accessible, and contribute to collective well-being.